Inventor · disambiguated record
Rolf Zinkernagel
Also filed as: ZINKERNAGEL ROLF · ZINKERNAGEL ROLF M
7 granted patents·4 pending applications·76 citations·filing 1999–2025
86Inventor score
Files withUNIV ZUERICH6ABBOTT LAB1INST NAT SANTE RECH MED1PINSCHEWER DANIEL D1UNIV ZUERICH PROREKTORAT MNW1
Top patents by PatentIndex Score
11 records- 0192US9944952B2Replication-defective arenavirus vectorsUNIV ZUERICH·Filed 2016·Granted Apr 17, 2018·13 cites·21 claims
- 0291US9309289B2Replication-defective arenavirus vectorsUNIV ZUERICH·Filed 2013·Granted Apr 12, 2016·15 cites·11 claims
- 0389US8592205B2Replication-defective arenavirus vectorsPINSCHEWER DANIEL D·Filed 2008·Granted Nov 26, 2013·21 cites·10 claims
- 0487US10655145B2Replication-defective arenavirus vectorsUNIV ZUERICH·Filed 2018·Granted May 19, 2020·5 cites·20 claims
- 0583US11401528B2Replication-defective arenavirus vectorsUNIV ZUERICH·Filed 2020·Granted Aug 2, 2022·1 cites·6 claims
- 0681US12227755B2Replication-defective arenavirus vectorsUNIV ZUERICH·Filed 2022·Granted Feb 18, 2025·0 cites·7 claims
- 0774US2025369015A1Replication-defective arenavirus vectorsUNIV ZUERICH·Filed 2025·Application pending·0 cites
- 0864US6506555B1Use of HIV protease inhibiting compoundsINST NAT SANTE RECH MED·Filed 1999·Granted Jan 14, 2003·21 cites·4 claims
- 0949US2010255001A1Blockers of serotonin and its receptors for the treatment of hepatitisUNIV ZUERICH PROREKTORAT MNW·Filed 2008·Application pending·0 cites
- 1043US2003082207A1Method of using HIV protease inhibiting compoundsFiled 2002·Application pending·0 cites
- 1141US2008063600A1Diagnostics And Therapeutics For Transmissible Spongiform Encephalopathy And Methods For The Manufacture Of Non-Infective Blood Products And Tissued Derived ProductsABBOTT LAB·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rolf Zinkernagel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →